Evidence map›Paper›PMID 39921685›Full record

ArticleBreast cancer (Tokyo, Japan)2025

Breast cancer screening rates and influencing factors among LGBTQ groups in Japan.

Akemi Hara, Akihiko Ozaki, Michio Murakami, Hiroaki Saito, Mika Nashimoto, Daisuke Hori, Masaharu Tsubokura, Kenji Gonda, Masahiro Wada, Kazunoshin Tachibana and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Breast cancer (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Akemi HaraMedical Governance Research Institute, Minato, Tokyo, Japan.
Akihiko OzakiMedical Governance Research Institute, Minato, Tokyo, Japan. ozakiakihiko@gmail.com.ORCID http://orcid.org/0000-0003-4415-9657
Michio MurakamiCenter for Infectious Disease Education and Research, Osaka University, Osaka, Japan.
Hiroaki SaitoDepartment of Internal Medicine, Soma Central Hospital, Soma, Fukushima, Japan.
Mika NashimotoKameda Medical Center Breast Center, Kamogawa, Chiba, Japan.
Daisuke HoriInstitute of Medicine, University of Tsukuba, Tsukuba, Japan.
Masaharu TsubokuraDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.
Kenji GondaBreast and Thyroid Center, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Masahiro WadaDepartment of Breast Surgery, Utsunomiya Central Clinic, Utsunomiya, Tochigi, Japan.
Kazunoshin TachibanaDepartment of Breast Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Tohru OhtakeDepartment of Breast Surgery, Fukushima Medical University, Fukushima, Fukushima, Japan.
Takahiro TabuchiDivision of Epidemiology, School of Public Health, Tohoku University Graduate School of Medicine, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLesbian, gay, bisexual, transgender, and queer (LGBTQ) individuals face significant health disparities worldwide, particularly in preventive medicine. In Japan, where breast cancer has the highest incidence rate among women, understanding screening behaviors among LGBTQ individuals is crucial for improving public health outcomes.

objectiveThis study aimed to elucidate the relationship between LGBTQ status and breast cancer screening behaviors in Japan, identifying factors influencing screening uptake and highlighting challenges in health management for the LGBTQ community.

methodsUsing data from the Japan COVID-19 and Society Internet Survey (JACSIS), we analyzed breast cancer screening status among 11,056 biological females. Multinomial logistic regression and stratified regression analyzes were employed to examine factors associated with screening behavior, comparing LGBTQ and non-LGBTQ groups.

resultsLGBTQ individuals demonstrated significantly lower odds of undergoing breast cancer screening (OR 0.82, 95% CI 0.73-0.91, p < 0.001) compared to non-LGBTQ individuals. Key factors influencing lower screening rates among individuals in the survey were primarily linked to LGBTQ identity, followed by higher rates of being uninsured, unmarried status, lower income levels, alcohol consumption. Stratified analysis revealed that uninsured LGBTQ individuals had significantly lower odds of screening (OR 0.23, 95% CI 0.08-0.70, p = 0.01) compared to those with national health insurance.

conclusionThis study identifies noteworthy differences in breast cancer screening behaviors between LGBTQ and non-LGBTQ individuals in Japan, as indicated by lower odds of screening participation among LGBTQ individuals, even after adjusting for socioeconomic factors. Findings underscore the need for targeted interventions, including improved healthcare access, LGBTQ-friendly medical environments, and awareness campaigns to address these disparities and promote health equity within the LGBTQ community.

Indexed as

Breast NeoplasmsEarly Detection of CancerSexual and Gender MinoritiesAdultAgedCOVID-19FemaleHealthcare DisparitiesHumansJapanMiddle AgedSurveys and QuestionnairesBreast neoplasmsEarly detection of cancerHealth care disparitiesHealth services accessibilitySexual and gender minorities

Identifiers

PMID39921685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.